Purpose-Built for Healthcare VC

Compliance Intelligence for the Next Generation of Healthcare Investors

Healthcare VC is surging—$15.3 billion in 2025 funding, record exits, and an AI revolution transforming care delivery. ChronoProof gives venture capital firms entering this space the compliance infrastructure to invest with confidence.

$15.3B
2025 HealthTech VC Funding
26.1%
YoY Funding Growth
141
VC Exits (All-Time High)
$31M
Median Pre-Money Valuation

THE OPPORTUNITY & THE CHALLENGE

Healthcare VC offers exceptional returns, but an 80% startup failure rate—often driven by regulatory barriers rather than product gaps—demands specialized tools for every stage of the investment lifecycle.

A Booming Market with High-Stakes Compliance

📈

AI Investment Dominance

AI drives healthtech allocation across clinical documentation ($1.2B in 2025), process automation ($620M), and clinical decision support ($608M). Categorization is increasingly complex as AI agents span multiple healthcare segments.

💰

PE Exit Pathway Surging

PE deal value rebounded to $13B (from $1.9B in 2024), and PE exits rose to $12.2B. PE acquirers demand exhaustive compliance documentation—creating a premium for well-governed portfolio companies.

🎯

Rising Valuations Raise the Bar

Median pre-money valuations climbed to $31M. Early-stage averages hit $50M—82.8% above the three-year average. Every investment decision carries heightened financial consequence, demanding deeper diligence.

🚀

IPO Pipeline Building

Five healthtech IPOs in 2025 (including Omada Health and Hinge Health). Late-stage companies like Sword Health, Spring Health, and Maven are 2026 IPO candidates with >80% predicted probability.

🔒

70% Rank Compliance #1

Seventy percent of VC firms identify compliance readiness as their top investment consideration. 83% of health plans and 81% of health systems demand stringent regulatory compliance from vendors before procurement.

⚠️

The Regulatory Sophistication Gap

60% of health system CIOs use 50+ point solutions, yet startups struggle to achieve enterprise-grade compliance certifications. Innovative products fail from compliance barriers—not product-market fit issues.

FOUR PRODUCTS. FULL LIFECYCLE.

Built for VCs Entering Healthcare

ChronoProof’s integrated suite covers every stage from deal sourcing to exit—giving new healthcare VCs an institutional-grade compliance layer from day one.

PRODUCT 01

ChronoScout

ChronoScout compresses healthcare deal evaluation from 30+ hours to approximately 2 hours—a 93% time reduction. It expands deal throughput from 4–6 deals per year to 40–50, letting new healthcare VCs screen the surging deal flow across all nine healthtech subsectors without building an in-house regulatory team.

AI-Powered Due Diligence

  • 45-page institutional-grade investment memoranda with executive summaries, market analysis, competitive positioning, and risk quantification
  • Six-risk-category framework with 85%+ confidence scoring: regulatory, cybersecurity, clinical validation, financial viability, competitive positioning, market timing
  • FDA pathway prediction, clinical trial modeling, HIPAA/HHS 405(d) assessment built into every evaluation
  • 247 sources analyzed per deal versus 45 in manual processes
  • $200K+ annual cost savings through productivity gains
93%
Time Reduction
20×
Throughput Increase
247
Sources Analyzed
$200K+
Annual Savings
Deal Screening Risk Scoring FDA Assessment Pattern Recognition Cost Reduction
HIPAA SOC 2 FDA 524B HHS 405(d) ISO 14971 ISO 13485 ICH Q9 EU MDR
Certification AccelerationHigh
M&A Exit ReadinessHigh
Valuation EnhancementHigh
Data SovereigntyMedium-High
Portfolio GRC Exit Prep Valuation Lift LP Confidence

PRODUCT 02

ChronoTruth

ChronoTruth is a comprehensive Governance, Risk, and Compliance platform purpose-built for healthcare. It allows VCs to deploy standardized compliance frameworks across portfolio companies operating in different subsectors—from digital care & treatments to revenue cycle management—each with distinct regulatory obligations.

Next-Generation GRC Platform

  • Covers HIPAA, SOC 2, FDA Section 524B, HHS 405(d), ISO 14971, ISO 13485, ICH Q9, and EU MDR frameworks
  • AI risk modeling & analysis with custom compliance roadmaps for each portfolio company
  • M&A exit readiness tools and data room preparation—critical as PE deal value surged to $13B in 2025
  • BYOC (Bring Your Own Cloud) architecture with immutable ledger storage and blockchain-anchored evidence hashes
  • Third-party risk management and documentation library with policy & procedure integration

PRODUCT 03

ChronoSee

ChronoSee provides standardized cybersecurity maturity assessments based on the HHS 405(d) framework—covering all 10 critical cybersecurity domains identified by the HHS 405(d) Task Group. Portfolio companies complete the online assessment in under one hour per quarter, with results immediately available to the VC.

Cybersecurity Assessment

  • All 10 HHS 405(d) cybersecurity domains assessed with standardized benchmarking across the portfolio
  • Under 1 hour per quarter per portfolio company—minimal operational disruption
  • Real-time risk visibility with AI implementation level and maturity assessment
  • Purchased by the VC and deployed across portfolio—fund-level control over risk oversight
  • Serves as a targeted cybersecurity deep-dive during later-stage due diligence
<1 hr
Per Company / Quarter
10
Security Domains Covered
Email ProtectionAssessed
Endpoint SecurityAssessed
Access ManagementAssessed
Data Protection & Loss PreventionAssessed
Network ManagementAssessed

PRODUCT 04

ChronoPulse is a Power BI-driven analytics and reporting dashboard providing portfolio-wide visibility. It aggregates compliance, cybersecurity, and ESG data across all portfolio companies into unified dashboards—giving new VCs a fund-level view that differentiates them when reporting to LPs and preparing for exits.

Analytics Dashboard

ChronoPulse

  • In-depth maturity analysis across each cybersecurity domain with drill-down by company, fund, or sector
  • Gap analysis with corrective action plans and risk simulations based on reported portfolio data
  • Aggregated fund-level ESG & GRC reporting aligned with growing LP transparency demands
  • Historical trend analysis to track whether corrective actions are improving compliance postures
  • AI implementation maturity assessment across portfolio for emerging governance needs
Fund-Level Aggregation
Gap Analysis & Simulations
ESG & GRC Reporting
Trend & Historical Analysis
AI Maturity Assessment
By Company By Fund By Sector LP Reports Risk Sims

FULL LIFECYCLE COVERAGE

One Platform, Every Investment Stage

ChronoProof maps to every phase of the healthcare VC investment lifecycle—from first deal screening through portfolio exit.

Investment Stage ChronoProof Product(s) Key Function
Deal Sourcing & Screening ChronoScout AI-powered due diligence, 20× throughput, 247-source analysis
Pre-Investment Deep Dive ChronoScout ChronoSee Regulatory risk scoring combined with cybersecurity assessment
Portfolio Onboarding ChronoTruth GRC platform deployment, custom compliance roadmaps
Ongoing Monitoring ChronoSee ChronoPulse Quarterly assessments, real-time analytics dashboards
Value Creation ChronoTruth ChronoPulse Certification acceleration, risk simulation, valuation enhancement
Exit Preparation ChronoTruth ChronoPulse M&A data room prep, documented compliance posture for PE/IPO
LP Reporting ChronoPulse Aggregated fund ESG/GRC reporting, compliance benchmarking

ChronoProof provides the compliance intelligence infrastructure that transforms regulatory complexity from a barrier into a competitive advantage.

Ready to Enter Healthcare VC with Confidence?